Title: Paul Naylor - Innovator in Immunotherapy
Introduction
Paul Naylor is an inventor based in Farmingdale, NY (US). He is currently associated with Irx Therapeutics, Inc. Naylor has made significant contributions to the field of immunotherapy, focusing on treatments for immune-suppressed patients. Although he does not hold any granted patents, his work is noteworthy for its potential impact on cancer treatment.
Latest Patent Applications
Naylor's patent application titled "Immunotherapy for Immune Suppressed Patients" presents compositions of a natural cytokine mixture (NCM) aimed at treating cellular immunodeficiencies characterized by T lymphocytopenia. The invention addresses one or more dendritic cell functional defects and monocyte functional defects. It includes methods for treating these immunodeficiencies using the NCM. The compositions and methods are particularly useful in treating diseases associated with cellular immunodeficiencies, such as cancer. Additionally, the application provides methods for reversing tumor-induced immune suppression through a combination of a chemical inhibitor and a non-steroidal anti-inflammatory drug (NSAID). A diagnostic skin test comprising NCM is also included for predicting treatment outcomes in cancer patients.
Conclusion
Paul Naylor's innovative work in immunotherapy highlights the importance of developing new treatments for immune-suppressed patients. His contributions, although not yet patented, have the potential to significantly advance cancer treatment methodologies.